The Tecan Symposium 2024●

Realizing the promise of liquid biopsy: Accelerating multiomic cancer solutions

 

September 26, 2024 • Boston, MA (USA)

REGISTER NOW

Overview

Liquid biopsy is set to revolutionize cancer screening and disease management. This year’s Tecan Symposium will unite global leaders in oncology to accelerate the development of accessible liquid biopsy applications as a complement to surgical approaches.

Join this exclusive event to share insights, build actionable partnerships and help to advance the field.

Read more about our 2023 Symposium in Nature.

Why join us?

In collaboration with our partners, we are pushing the boundaries of liquid biopsy research and helping to develop clinically approved tools for widespread and immediate use. We embrace a broad, multi-omics approach to accelerate the next generation of personalized treatments, enabling faster, more cost-effective access for those in need.

The Tecan Symposium brings together the work of influential liquid biopsy organizations. Bring your unique perspective and help make meaningful progress.

Introduction – Breaking barriers: advancing clinical application of liquid biopsy solutions through research, clinical and industry collaboration.

Achim von Leoprechting
Chief Executive Officer
Tecan
View profile >

Keynote address – Partnering for progress: working collaboratively to make blood-based cancer screening and disease management a global clinical standard.

Lauren Leiman
Executive Director
BloodPAC
View profile >

Who will attend?

We’re inviting key decision-makers from academia and the liquid biopsy technology sector, including CTOs, CMOs, CSOs, medical oncologists and drug development professionals. Together with leading researchers, regulators, private investors and advocacy organizations, the gathering aims to foster meaningful discussions among those positioned to act. It will focus on active participation and personal commitment to ensure that conversations can be translated into actionable steps.

Moderated by our organizational partners and liquid biopsy experts, the Tecan Symposium comprises three roundtable discussions of the future of liquid biopsy:

Research, standards and protocols

Standardizing Next Generation Sequencing protocols for liquid biopsy applications, such as multi-cancer early detection and molecular residual disease, presents numerous challenges. Drawing from both industry and academic experiences, what does the future hold for proteomics- and multiomics-based liquid biopsy assays?

Moderated by:

Rolfo

Christian Rolfo
President
International Society of Liquid Biopsy
View profile >

Clinical validation of innovation

How can we streamline post-surgical liquid biopsy to set fast, robust, and flexible clinical trial standards? Accelerating validation and approval processes will boost investment and promote data sharing. To enhance sensitivity, what technological hurdles must we address, and which key variables should we measure?
 

Moderated by:

Pantel

Klaus Pantel
President
European Liquid Biopsy Society
View profile >

Accessibility and affordability

The implementation of clinical standards for blood-based cancer screening and disease management is long overdue. How do we accelerate the availability of affordable solutions and how can we reach underserved populations?
 
 

Moderated by:

Bramlet

Kelli Bramlett
Executive Director
Molecular Oncology, Quest Diagnostics
View profile >

Past Speakers

The Tecan Symposium is an opportunity for leaders to gather, whether from industry, research and clinical practices. Our speakers are at the cutting edge of their fields, ready to collaborate, build understanding and accelerate progress.

Jeffrey M. Venstrom
Chief Medical Officer
GRAIL
View profile >

Alanna Church
Boston Children’s Hospital
View profile >

Alexander Gusev
Dana-Farber Cancer Institute
View profile >

Vivek Subbiah
Sarah Cannon Research Institute
View profile >

Catherine Wu
Dana-Farber Cancer Institute
View profile >

Achim von Leoprechting
CEO
Tecan
View profile >

Darrell Irvine
MIT, Koch Institute for Integrative Cancer Research
View profile >

Kfir Schreiber
CEO & Co-Founder
Deepcure AI
View profile >

Saheli Sadanand
Deputy Editor
Nature Medicine
View profile >

Wael Yared
CTO
Tecan
View profile >

Join us by registering!


Block your calendars and sign up to attend. As seats are limited, a Tecan representative will contact you to ensure the right delegates from your organization can participate.
How do we use your data?